Please upgrade your browser.
President Barack Obama is the first new President to develop a comprehensive cancer plan. While the plan reflects strong emphasis on oncology, disturbingly no reference is made to prevention, and the wide range of avoidable causes of cancer.
The role of laparoscopic radical nephrectomy (LRN) for very large renal tumors remains to be defined. We review our experience with LRN for very large (>/=10 cm) renal malignancies.
The fundraiser for Luke Bludau, a Serene Hills Elementary kindergartener with kidney cancer, drew more than 200 children and their families.
The drugs, Sutent, Nexavar, Avastin and Torisel, havent yet been approved by the National Institute for Health and Clinical Excellence (Nice) for use in the NHS.
S. Duke Herrell, M.D., associate professor of Urologic Surgery at Vanderbilt-Ingram Cancer Center, has performed the first robotic laparoscopic kidney cancer surgery at Vanderbilt University Medical Center.
Afinitor is being studied in multiple cancer types including advanced kidney, breast and neuroendocrine tumors and lymphoma.
Bayer HealthCare and the Association of German Medical Journalists (VDMJ) have jointly announced the 2009 Advances in Renal Cancer Journalists Award Europe, which will honor journalists who have dealt with the issue of renal cancer in a critical and objective manner.
46-year-old Tim Buehner has been battling kidney cancer since last February.
The National Comprehensive Cancer Network (NCCN) has been awarded a $4 million grant from Wyeth Pharmaceuticals to support clinical studies of temsirolimus (Torisel(R),
Jack Rosser of South Gloucestershire. Rosser has advanced kidney cancer and would likely benefit from Sutent, a drug widely used in the United States for such patients. Rosser's doctor has said that Sutent could well add years to his life. However, as Bloomberg reports, "The U.K.'s National Health Service (NHS) says that's not worth the expense."
|Powered by NeonCRM|